Schizophrenia & Other Psychotic Disorders
Video
Tardive dyskinesia: Screening and management
Sanjay Gupta, MD, discusses 2 new treatments for tardive dyskinesia.
MDedge Psychcast
Schizophrenia: Psychiatrists ‘can do much more’ for patients
This is episode #2 of the MDedge Psychcast, the new podcast from Clinical Psychiatry News and Current Psychiatry.
Daily News Podcast
MDedge Daily News: Lupus is quietly killing young women
And does substance abuse trigger schizophrenia?
From the Journals
Substance use linked to conversion to schizophrenia
Individuals with schizotypal disorder who use cannabis, opioids, or amphetamines have a higher risk of converting to schizophrenia.
Conference Coverage
Real-world data so far support pimavanserin trial results
LOS ANGELES – Two studies report on clinicians’ experiences with 105 patients.
From the Journals
Targeting obesity could slow brain aging in psychosis
"The brains of participants with [first-episode psychosis] appeared on average 2.64 years older than their chronological age."
Podcasts
MDedge Psychcast: Interview with Dr. Henry Nasrallah
This is the first episode of our new psychiatry podcast.
From the Journals
Early trauma exposure tied to telomere shortening in men with schizophrenia
“Pathobiology of schizophrenia may lie ... in the mechanisms related to sexual differentiation.”
From the Journals
Consanguineous parentage raises risk of mood disorders, psychoses in offspring
Children of first-cousin consanguineous parents are at greater risk of being prescribed psychotropic medications than those born to nonrelated...
Evidence-Based Reviews
Aripiprazole, brexpiprazole, and cariprazine: Not all the same
Understanding the key differences among these agents can help inform treatment decisions.
Podcasts
Aripiprazole, brexpiprazole, and cariprazine
Leslie Citrome, MD, MPH, discusses the differences among 3 dopamine receptor partial agonists.